Stimulatory Effect of Secretin on Pancreatic Polypeptide in diabetic Patients

In diabetic patients plasma levels of pancreatic polypeptide (PP) increased four fold after intramuscular injection of secretin (50CHRU, Eisai Co.) in spite of the lack of response of plasma insulin, plasma glucagon and blood glucose levels. In control subjects, PP levels did not change significantl...

Full description

Saved in:
Bibliographic Details
Published inEndocrinologia Japonica Vol. 27; no. 2; pp. 145 - 147
Main Authors TOYOTA, TAKAYOSHI, KOIZUMI, MASARU, KAI, YUKIHIRO, MIURA, MORIMASA, UMETSU, MASANORI, SUZUKI, Susumu, GOTO, YOSHIO
Format Journal Article
LanguageEnglish
Published Japan The Japan Endocrine Society 01.01.1980
Subjects
Adult
Aged
Blood Glucose - analysis
Diabetes Mellitus - blood
Glucagon - blood
Humans
Injections, Intramuscular
Insulin - blood
Middle Aged
Pancreatic Polypeptide - blood
Secretin - pharmacology
Online AccessGet full text

Cover

More Information
Summary:In diabetic patients plasma levels of pancreatic polypeptide (PP) increased four fold after intramuscular injection of secretin (50CHRU, Eisai Co.) in spite of the lack of response of plasma insulin, plasma glucagon and blood glucose levels. In control subjects, PP levels did not change significantly after secretin injection. Since pancreatic polypeptide has is known to have an inhibitory effect on the exocrine pancreas, the present study suggests the possibility that disturbed function of the exocrine pancreas in diabetic patients could be related to the remarkable response of PP to secretin-stimulation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0013-7219
2185-6370
DOI:10.1507/endocrj1954.27.145